Scientists develop a technology to find "jumping genes," a type of genetic element that may contribute to antibiotic resistance.
People with a mutation in an enzyme that breaks down alcohol may be at a higher risk for developing Alzheimer's disease, new research suggests.
In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.
A Stanford biomedical data scientist discusses how computational modeling of big data could help improve personalized chemotherapy selection in the future.
Through genetic tests and databases of symptoms, doctors in a network of clinical centers help families determine what is affecting their children's health.
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
Stanford scientists have conducted a proof-of-concept experiment in mice that shows they can use blood stem cells to treat a severe brain disease.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
The conclusion of this series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics really improve health.
Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.
Scientists at Stanford use a gene therapy technique, called RNA silencing, to treat a heart condition called restrictive cardiomyopathy in mice.
A Stanford scientist and his son harness RNA sequencing to discover the genomic mutation behind the uncommon California poppy.
Stanford scientists have found 16 new genetic variants linked to a greater risk for autism, a finding that could help identify biomarkers for the disorder.
Researchers at Stanford have created an algorithm that predicts how likely CRISPR gene editing will yield off-target mutations.
This In the Spotlight features Helio Costa, a geneticist who has developed an assay currently being used to help cancer patients.
Amy Adams discusses her journey from future PhD geneticist to science writer and calls for a more nuanced look at gender representation in STEM fields.
